Tirmed Pharma

TIRmed Pharma´s product candidate is a chemically stabilized, single-stranded oligonucleotide, which has non-coding and non-complementary sequence. The compound is formulated in a cream aiming for a self-applied and easy to use at-home anti-itch treatment. The product through its mode-of-action, which saves vital immune defenses and has anti-itch effects, would have potential for safe and effective treatment of mild to moderate atopic dermatitis. Atopic dermatitis is associated with a disrupted skin barrier facilitating entry of external allergens and compounds for treatment. Topical delivery to the skin limits systemic adverse events. TIRmed´s cream is intended for early mild-moderate symptoms to limit the use of biologicals.